# JEMPERLI
> **BLA761174** · Biologics License Application · Sponsor: GLAXOSMITHKLINE · Approved 2021-04-22
## Drug
- **FDA Application Number:** BLA761174
- **Application type:** Biologics License Application
- **Brand name:** JEMPERLI
- **Generic name:** DOSTARLIMAB
- **Active ingredients:** DOSTARLIMAB-GXLY
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2021-04-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761174)
---
*AI Analytics · CC0 1.0*